Bristol-Myers Gets Pushback On Early Win Bid Over Cancer IP
Bristol-Myers Squibb Co. faced headwinds in Boston federal court Wednesday in arguing for a pretrial win in a lawsuit claiming it robbed Dana-Farber Cancer Institute of licensing revenue from groundbreaking immunology...To view the full article, register now.
Already a subscriber? Click here to view full article